ArrowMark Colorado Holdings’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
VCM
VPM
ArrowMark Colorado Holdings's HALO Position: Q1 2026 in Review
ArrowMark Colorado Holdings reduced its Halozyme (HALO) stake by 9% in Q1 2026, selling an estimated $3.98M and leaving 569,789 shares worth $36.8M. The position accounts for 0.98% of the portfolio, ranked #27.
ArrowMark Colorado Holdings first reported a position in HALO in Q3 2013 and has held it in 17 quarters since. The position peaked at $115M in Q3 2024. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- ArrowMark Colorado Holdings held 569,789 shares of Halozyme worth $36.8M as of Q1 2026.
- ArrowMark Colorado Holdings sold 56,429 Halozyme shares in Q1 2026, an estimated $3.98M.
- Halozyme made up 0.98% of ArrowMark Colorado Holdings's portfolio in Q1 2026, its #27 holding.
- ArrowMark Colorado Holdings first reported a position in Halozyme in Q3 2013 and has held it in 17 quarters since.
- ArrowMark Colorado Holdings's Halozyme position peaked at $115M in Q3 2024.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on ArrowMark Colorado Holdings's 13F filing for Q1 2026, filed 15 May 2026.